Journal of International Oncology ›› 2021, Vol. 48 ›› Issue (3): 164-166.doi: 10.3760/cma.j.cn371439-20200401-00032
• Reviews • Previous Articles Next Articles
Fan Chongchong, Qiao Jian'ou*()
Received:
2020-04-01
Revised:
2020-11-15
Online:
2021-03-08
Published:
2021-03-25
Contact:
Qiao Jian'ou
E-mail:qjou@163.com
Supported by:
Fan Chongchong, Qiao Jian'ou. Thrombospondin 2 and tumors[J]. Journal of International Oncology, 2021, 48(3): 164-166.
[1] |
Weng TY, Wang CY, Hung YH, et al. Differential Expression pattern of THBS1 and THBS2 in lung cancer: clinical outcome and a systematic-analysis of microarray databases[J]. PLoS One, 2016,11(8):e0161007. DOI: 10.1371/journal.pone.0161007.
doi: 10.1371/journal.pone.0161007 pmid: 27513329 |
[2] | Kim J, Bamlet WR, Oberg AL, et al. Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers[J]. Science Translational Medicine, 2017,9(398):eaah5583. DOI: 10.1126/scitranslmed.aah5583. |
[3] | Wang X, Zhang L, Li H, et al. THBS2 is a potential prognostic biomarker in colorectal cancer[J]. Sci Rep, 2016,6:33366. DOI: 10.1038/srep33366. |
[4] |
Sun R, Wu J, Chen Y, et al. Down regulation of thrombospondin2 predicts poor prognosis in patients with gastric cancer[J]. Mol Cancer, 2014,13:225. DOI: 10.1186/1476-4598-13-225.
doi: 10.1186/1476-4598-13-225 pmid: 25262009 |
[5] | 吴湘光, 魏文斐, 梁莉, 等. THBS2在宫颈癌中的表达及功能研究[J]. 现代妇产科进展, 2017,26(12):889-892. DOI: 10.13283/j.cnki.xdfckjz.2017.12.002. |
[6] |
Koch M, Hussein F, Woeste A, et al. CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo[J]. Breast Cancer Res Treat, 2011,128:337-346. DOI: 10.1007/s10549-010-1085-7.
doi: 10.1007/s10549-010-1085-7 pmid: 20714802 |
[7] |
Carlson CB, Lawler J, Mosher DF. Structures of thrombospondins[J]. Cell Mol Life Sci, 2008,65(5):672-686. DOI: 10.1007/s00018-007-7484-1.
pmid: 18193164 |
[8] | Mirochnik Y, Kwiatek A, Volpert OV. Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments[J]. Curr Drug Targets, 2008,9(10):851-862. DOI: 10.2174/138945008785909347. |
[9] | Calabro NE, Kristofik NJ, Kyriakides TR. Thrombospondin-2 and extracellular matrix assembly[J]. Biochim Biophys Acta, 2014,1840(8):2396-2402. DOI: 10.1016/j.bbagen.2014.01.013. |
[10] | Bornstein P. Thrombospondins as matricellular modulators of cell function[J]. J Clin Invest, 2001,107(8):929-934. DOI: 10.1172/JCI12749. |
[11] |
Liu JF, Lee CW, Tsai MH, et al. Thrombospondin 2 promotes tumor metastasis by inducing matrix metalloproteinase-13 production in lung cancer cells[J]. Biochem Pharmacol, 2018,155:537-546. DOI: 10.1016/j.bcp.2018.07.024.
doi: 10.1016/j.bcp.2018.07.024 pmid: 30031810 |
[12] |
Del Pozo Martin Y, Park D, Ramachandran A, et al. Mesenchymal cancer cell-stroma crosstalk promotes niche activation, epithelial reversion, and metastatic colonization[J]. Cell Rep, 2015,13(11):2456-2469. DOI: 10.1016/j.celrep.2015.11.025.
pmid: 26670048 |
[13] | 杨柳, 罗黔. 胰腺癌组织高表达血小板反应蛋白2的预后意义及其对癌细胞增殖和迁移的影响[J]. 中国肿瘤生物治疗杂志, 2019,26(2):206-212. DOI: 10.3872/j.issn.1007-385x.2019.02.011. |
[14] |
Peng HY, Chang MC, Hu CM, et al. Thrombospondin-2 is a highly specific diagnostic marker and is associated with prognosis in pancreatic cancer[J]. Ann Surg Oncol, 2019,26(3):807-814. DOI: 10.1245/s10434-018-07109-6.
doi: 10.1245/s10434-018-07109-6 pmid: 30569296 |
[15] | 蒋炳林, 何永亮, 陈开蓉. MMP3、THBS2、COL10A1和miR-1229对早期结直肠癌的诊断价值[J]. 标记免疫分析与临床, 2019,26(6):994-999. DOI: 10.11748/bjmy.issn.1006-1703.2019.06.024. |
[16] | 贺春兰, 张梦兰, 杨勇, 等. 血小板反应素蛋白2在高原地区胃黏膜炎性病变及胃癌患者中表达的差异研究[J]. 中国全科医学, 2016,19(26):3185-3190. DOI: 10.3969/j.issn.1007-9572.2016.26.012. |
[17] | Wei WF, Zhou CF, Wu XG, et al. MicroRNA-221-3p, a TWIST2 target, promotes cervical cancer metastasis by directly targeting THBS2[J]. Cell Death Dis, 2017,8(12):3220. DOI: 10.1038/s41419-017-0077-5. |
[18] | Calabro NE, Barrett A, Chamorro-Jorganes A, et al. Thrombospondin-2 regulates extracellular matrix production, LOX levels, and cross-linking via downregulation of miR-29[J]. Matrix Biol, 2019,82:71-85. DOI: 10.1016/j.matbio.2019.03.002. |
[19] | 董婷婷, 戴盛康, 龙颖, 等. 过表达THBS2对宫颈鳞癌SiHa细胞生物学特性的影响[J]. 中国癌症防治杂志, 2018,10(6):427-433. DOI: 10.3969/j.issn.1674-5671.2018.06.02. |
[20] |
Bertin N, Clezardin P, Kubiak R, et al. Thrombospondin-1 and -2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia[J]. Cancer Res, 1997,57(3):396-399.
pmid: 9012463 |
[21] | 莫超华. 基于芯片、测序数据及CMAP方法对乳腺癌差异表达基因的研究[D]. 南宁: 广西医科大学, 2018. |
[22] |
Hsu CW, Yu JS, Peng PH, et al. Secretome profiling of primary cells reveals that THBS2 is a salivary biomarker of oral cavity squamous cell carcinoma[J]. J Proteome Res, 2014,13(11):4796-4807. DOI: 10.1021/pr500038k.
doi: 10.1021/pr500038k |
[23] |
Chang IW, Li CF, Lin VC, et al. Prognostic impact of thrombospo-din-2 (THBS2) overexpression on patients with urothelial carcinomas of upper urinary tracts and bladders[J]. J Cancer, 2016,7(11):1541-1549. DOI: 10.7150/jca.15696.
doi: 10.7150/jca.15696 pmid: 27471570 |
[24] |
Slavin S, Yeh CR, Da J, et al. Estrogen receptor α in cancer-associated fibroblasts suppresses prostate cancer invasion via modulation of thrombospondin 2 and matrix metalloproteinase 3[J]. Carcinogenesis, 2014,35(6):1301-1309. DOI: 10.1093/carcin/bgt488.
pmid: 24374826 |
[25] |
Zhang J, Hao N, Liu W, et al. In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery[J]. Br J Cancer, 2017,117(11):1676-1684. DOI: 10.1038/bjc.2017.344.
pmid: 29024941 |
[1] | Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343. |
[4] | Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p, H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349. |
[5] | Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353. |
[6] | Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358. |
[7] | Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363. |
[8] | Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[9] | Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375. |
[10] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[11] | Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273. |
[12] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279. |
[13] | Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285. |
[14] | Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291. |
[15] | Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||